A high content screening assay to predict human drug-induced liver injury during drug discovery.


INTRODUCTION Adverse drug reactions are a major cause for failures of drug development programs, drug withdrawals and use restrictions. Early hazard identification and diligent risk avoidance strategies are therefore essential. For drug-induced liver injury (DILI), this is difficult using conventional safety testing. To reduce the risk for DILI, drug… (More)
DOI: 10.1016/j.vascn.2013.08.001


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics